Imatinib 2
PROVEER MEDICAMENTOS A PACIENTES BENEFICIARIOS DEL HBSJO
2 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1063535-6740-SE26 | 03-07-2026 | Laboratorio Chile S.A. | $417.690 |
| 1063535-6558-SE26 | 12-06-2026 | Laboratorio Chile S.A. | $417.690 |
| 1063535-6313-SE26 | 13-05-2026 | Laboratorio Chile S.A. | $417.690 |
| 1063535-6018-SE26 | 13-04-2026 | Laboratorio Chile S.A. | $348.075 |
| 1063535-5647-SE26 | 05-03-2026 | Laboratorio Chile S.A. | $417.690 |
| 1063535-5355-SE26 | 03-02-2026 | Laboratorio Chile S.A. | $417.690 |
| 1063535-5142-SE26 | 13-01-2026 | Laboratorio Chile S.A. | $348.075 |
| 1063535-16810-SE25 | 03-12-2025 | Laboratorio Chile S.A. | $417.690 |
| 1063535-16466-SE25 | 15-10-2025 | Laboratorio Chile S.A. | $160.650 |
| 1063535-16427-SE25 | 13-10-2025 | Laboratorio Chile S.A. | $417.690 |
| 1063535-10321-SE25 | 17-09-2025 | Laboratorio Chile S.A. | $417.690 |
| 1063535-10229-SE25 | 04-09-2025 | Novartis Chile S.A. | $3.214.071 |
| 1063535-10035-SE25 | 13-08-2025 | Novartis Chile S.A. | $2.142.714 |
| 1063535-9877-SE25 | 25-07-2025 | Novartis Chile S.A. | $5.356.785 |
| 1063535-9735-SE25 | 10-07-2025 | Novartis Chile S.A. | $5.356.785 |
| 1063535-9727-SE25 | 09-07-2025 | Laboratorio Chile S.A. | $321.300 |
| 1063535-9579-SE25 | 18-06-2025 | Novartis Chile S.A. | $3.214.071 |
| 1063535-9452-SE25 | 04-06-2025 | Novartis Chile S.A. | $3.214.071 |
| 1063535-9209-SE25 | 08-05-2025 | Novartis Chile S.A. | $4.285.428 |
| 1063535-8968-SE25 | 11-04-2025 | Novartis Chile S.A. | $4.285.428 |
| 1063535-6377-SE25 | 20-03-2025 | Novartis Chile S.A. | $4.285.428 |
| 1063535-570-SE25 | 04-03-2025 | Novartis Chile S.A. | $4.285.428 |
| 1063535-362-SE25 | 10-02-2025 | Novartis Chile S.A. | $4.285.428 |
| 1063535-210-SE25 | 23-01-2025 | Novartis Chile S.A. | $4.285.428 |
| 1063535-2894-SE24 | 17-12-2024 | Novartis Chile S.A. | $4.285.428 |
| 1063535-2801-SE24 | 06-12-2024 | Novartis Chile S.A. | $3.214.071 |
| 1063535-2676-SE24 | 15-11-2024 | Novartis Chile S.A. | $3.214.071 |
| 1063535-2579-SE24 | 06-11-2024 | Novartis Chile S.A. | $3.214.071 |
| 1063535-2417-SE24 | 16-10-2024 | Novartis Chile S.A. | $3.214.071 |
| 1063535-2320-SE24 | 02-10-2024 | Laboratorio Chile S.A. | $2.045.610 |
| 1063535-2271-SE24 | 26-09-2024 | Novartis Chile S.A. | $4.285.428 |
| 1063535-2077-SE24 | 03-09-2024 | Novartis Chile S.A. | $3.214.071 |
| 1063535-1945-SE24 | 22-08-2024 | Novartis Chile S.A. | $2.142.714 |
| 1063535-1656-SE24 | 18-07-2024 | Novartis Chile S.A. | $4.285.428 |
| 1063535-1487-SE24 | 24-06-2024 | Novartis Chile S.A. | $4.285.428 |
| 1063535-1347-SE24 | 03-06-2024 | Novartis Chile S.A. | $4.285.428 |
| 1063535-1164-SE24 | 14-05-2024 | Novartis Chile S.A. | $3.214.071 |
| 1063535-1079-SE24 | 03-05-2024 | Novartis Chile S.A. | $3.214.071 |
| 1063535-956-SE24 | 18-04-2024 | Laboratorio Chile S.A. | $208.845 |
| 1063535-893-SE24 | 09-04-2024 | Novartis Chile S.A. | $3.214.071 |
| 1063535-686-SE24 | 12-03-2024 | Novartis Chile S.A. | $5.356.785 |
| 1063535-466-SE24 | 15-02-2024 | Novartis Chile S.A. | $4.285.428 |
| 1063535-226-SE24 | 18-01-2024 | Novartis Chile S.A. | $4.285.428 |
| 1063535-12-SE24 | 02-01-2024 | Novartis Chile S.A. | $4.285.428 |
| 1063535-3321-SE23 | 18-12-2023 | Novartis Chile S.A. | $3.214.071 |
| 1063535-3208-SE23 | 11-12-2023 | Novartis Chile S.A. | $3.214.071 |
| 1063535-2862-SE23 | 06-11-2023 | Laboratorio Chile S.A. | $208.845 |
| 1063535-2836-SE23 | 03-11-2023 | Novartis Chile S.A. | $7.499.499 |
Fuente original:ficha mercadopublico.cl
